Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases.
Brano Therapeutics has raised $6.8M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Brano Therapeutics's investors include LIVE Ventures., SGInnovate, Seeds Capital, Trinity Innovation Bioventure Singapore.
Brano Therapeutics is headquartered in Singapore, Singapore.
Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases.
Brano Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Brano Therapeutics — Funding & Investors." VCBacked, May 6, 2026, https://www.vcbacked.co/company/brano-therapeutics. Accessed October 7, 2026.
VCBacked. (2026). Brano Therapeutics — Funding & Investors. Retrieved October 7, 2026, from https://www.vcbacked.co/company/brano-therapeutics
{{cite web |title=Brano Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/brano-therapeutics |website=VCBacked |access-date=October 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated